Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SGRY
    4. >
  4. Valuation

Valuation

-
stocks logo
SGRY
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is SGRY Overvalued？

SGRY is now in the zone, suggesting that SGRY current forward PE ratio of 27.86 is considered compare with the five-year average of -334.74.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

SGRY Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
SGRY.O
Surgery Partners Inc
27.86
Average P/E: 12.48
-544.70%
3.18B
stocks logo
SEM.N
Select Medical Holdings Corp
16.72
Average P/E: 12.48
15.70%
2.39B
stocks logo
PACS.N
Pacs Group Inc
8.27
Average P/E: 12.48
-144.28%
2.05B
stocks logo
ARDT.N
Ardent Health Partners Inc
8.11
Average P/E: 12.48
15.82%
2.00B
stocks logo
PINC.O
Premier Inc
13.96
Average P/E: 12.48
1.66B
stocks logo
NHC.A
National Healthcare Corp
0.00
Average P/E: 12.48
302.89%
1.43B

SGRY Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

SGRY FAQs

Is SGRY currently overvalued based on its P/E ratio?

According to the provided data, SGRY's 5-year historical average forward P/E ratio is -334.48. SGRY forward P/E ratio is 27.86, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for SGRY?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has SGRY's Price to Sales (PS) ratio evolved?

The PS ratio increased from 1.04 to 1.36, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for SGRY's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

SGRY PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
-334.74
Current PE
27.86
Overvalued PE
1272.54
Undervalued PE
-1942.02

SGRY EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
18.59
Current EV
14.62
Overvalued EV
21.78
Undervalued EV
15.40

SGRY P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
1.18
Current PS
0.97
Overvalued PS
1.66
Undervalued PS
0.70

SGRY Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
SGRY.O
Surgery Partners Inc
27.86
Average P/E: 12.48
-544.70%
3.18B
stocks logo
SEM.N
Select Medical Holdings Corp
16.72
Average P/E: 12.48
15.70%
2.39B
stocks logo
PACS.N
Pacs Group Inc
8.27
Average P/E: 12.48
-144.28%
2.05B
stocks logo
ARDT.N
Ardent Health Partners Inc
8.11
Average P/E: 12.48
15.82%
2.00B
stocks logo
PINC.O
Premier Inc
13.96
Average P/E: 12.48
1.66B
stocks logo
NHC.A
National Healthcare Corp
0.00
Average P/E: 12.48
302.89%
1.43B

SGRY Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is SGRY undervalued？Is SGRY overvalued compared to its competitors？

SGRY FAQs

Is SGRY currently overvalued based on its P/E ratio?

According to the provided data, SGRY's 5-year historical average forward P/E ratio is -334.48. SGRY forward P/E ratio is 27.86, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for SGRY?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has SGRY's Price to Sales (PS) ratio evolved?

The PS ratio increased from 1.04 to 1.36, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for SGRY's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is SGRY undervalued？Is SGRY overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free